What is GlucoSet?
GlucoSet is at the forefront of medical technology, specializing in the development of innovative tools for continuous glucose monitoring. Their primary focus is on Intensive Care Units (ICUs), where their minimally invasive sensor technology offers accurate glucose monitoring without the need for new catheters. This ease of adoption for nursing staff, coupled with a design emphasizing reliability and low complexity, addresses long-standing challenges in the field. The company's commitment to advancing patient care and optimizing hospital economics is supported by a strong patent portfolio and a team of seasoned experts.
How much funding has GlucoSet raised?
GlucoSet has raised a total of $6.5M across 1 funding round:
Series A
$6.5M
Series A (2023): $6.5M with participation from The European Innovation Council and Diabetes Center Berne
Key Investors in GlucoSet
The European Innovation Council
The European Innovation Council is an entity operating within the Colleges & Universities sector, indicating a potential focus on research-backed innovation and early-stage technological advancements.
Diabetes Center Berne
The Diabetes Center Berne is a non-profit organization dedicated to research and development in diabetes mellitus, focusing on unmet needs and supporting translational research from laboratory to market. Their involvement suggests a strong alignment with GlucoSet's mission in diabetes management.
What's next for GlucoSet?
With this substantial Series A financing, GlucoSet is poised for significant expansion and further product development. The strategic investment will likely fuel the scaling of their operations, enabling broader market penetration and the enhancement of their continuous glucose monitoring solutions. The company's trajectory suggests a focus on solidifying its position in the critical care market and potentially exploring new applications for its technology. Future endeavors will likely involve leveraging this capital to accelerate clinical validation, expand manufacturing capabilities, and strengthen commercialization efforts, aiming to establish new benchmarks in diabetes management within hospital settings.
See full GlucoSet company page
